<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">
Log In

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Neurovascular Intervention: Trends to Watch in 2026

3/10/26 9:32 AM

Neurovascular 2026 Header v99SmartTRAK highlights three neurointerventional trends to watch in 2026.

SmartTRAK highlights recent news, research and trends in the market for neurointerventional devices and what’s impacting the US Market for Mechanical Thrombectomy, which is projected to reach a 5-year CAGR of +8.0% according to SmartTRAK. In this comprehensive, downloadable article, three neurointerventional trends to watch in 2026 are discussed in detail. They are:

1. Shift to Precision Thrombectomy - In 2026, SmartTRAK anticipates slower growth to continue in the treatment of patients with distal and medium vessel occlusions (DMVO) following the publication of several randomized controlled trials in 2025 (DISTAL, ESCAPE-MeVO, DISCOUNT) that found ... (read more)

2. Greater Focus on Expanded Indications - Companies competing in the market for neurointervention have been working closely with physicians, conducting research and leveraging neurovascular devices for use in adjacent markets and other indications, including ... (read more

3. Momentum Builds in the Intrasaccular Flow Disruptor Segment - In 2025, Terumo marked the 15-year anniversary of its WEB Aneurysm Embolization System, maintaining its single-player US market dominance in the intrasaccular flow disruptor market. That same year, the neurovascular space saw a surge of clinical activity in the segment, with multiple devices entering or advancing through clinical trials, showcasing ... (read more

Click the button below to download the complete "Neurovascular Intervention: Trends to Watch in 2026" Market Outlook article by Anne Staylor, SmartTRAK Executive Editor, VP & GM of Neuro Therapies and Tracy Martellotta, Senior Analyst. Get the Article


SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.

Anne Staylor
Written by Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles